Blue Horseshoe Stocks: Pharma News Watchlist & More

Pharma News Watchlist:

We’ve got a trio of pharma plays to add to our watchlist on the heels of fresh news releases for each of them this morning. Each stock is gapping up significantly in the premarket, and we’ll be waiting in the wings once the session commences to see if we can use the resulting activity to our advantage.

Akebia Therapeutics, Inc. AKBA – Per the newly announced agreement out today, AKBA has entered into a Collaboration and License Agreement to carry forward with the development of one of its treatments. The deal comes with an immediate payment of $125M, a cash infusion that represents roughly 40% of the company’s total market cap as of yesterday.

______

ACADIA Pharmaceuticals, Inc. ACAD – In the case of ACAD, we’ve gotten word of positive top-line results in a Phase II study it was conducting on the company’s Alzheimer’s drug.  To leverage the present activity to our advantage here, we’re going to track the ACAD Weekly $28-31 Calls. (>>View PR)

_______

Conatus Pharmaceuticals, Inc. CNAT

Here we have another collaboration and licensing deal, for CNAT’s liver drug, which is going to be bringing a $50M cash infusion Conatus’ way. That’s just the initial tranche, with more payments to follow as outlined in the relevant filing (>>View 8-K)


Globalstar, Inc. GSAT

We put GSAT on watch as a possible momentum play in yesterday morning’s premarket report, and while it didn’t break out in a major way, it did continue the trend of solid upward momentum that has been observed in recent sessions. From an early low of 1.25, the stock ran as high as 1.60; a 28% pop.

The performance, while not astronomical, was certainly enough to hold our interest in continuing to monitor GSAT’s activity moving forward.


Cellectar Biosciences, Inc. CLRB – Reminder

We just wanted to take a quick moment to reiterate a possible bottom-play selection we made last week in the form of CLRB. We’re still tracking this one, and think it has a good chance to produce a recovery, possibly following the holiday break. So we’re going to want to leave a space on our watch screens reserved for CLRB in the days and weeks ahead.


Extended Watchlist:
AXPW, CAPS, MFST, ENDV, ETRM, EXAD

Blue Horseshoe Stocks: Shipping Watchlist & More

Shipping Sector Watchlist

Earlier this fall, we found an incredible amount of success within the shipping sector, as an industry-wide wave of bullish activity carried many related stocks to record moves.

That rush tuckered out a few weeks back, but we want to circle back around this morning to cast a light on several of these stocks that we think could be gearing up for a recovery. Each of the following had been in a drastic downturn leading into yesterday’s session, and each of them began to show some major signs of life in coming off their bottoms.

We’ll want to keep all of them in mind in coming sessions, and watch for signs that a more sustained uptrend could take effect.

Dry Ships, Inc. DRYS

Sino-Global Shipping America, Ltd. SINO

Diana Containerships, Inc. DCIX

Diana Shipping, Inc. DSX

Seanergy Maritime Holdings Corp. SHIP

Euroseas Ltd. ESEA

Global Ship Lease, Inc. GSL


Catalyst Biosciences, Inc. CBIO

We stipulated yesterday that if CBIO held above .80 on any early pullbacks, that we’d be interested in tracking its activity through the session, and it did just that.

The intraday machinations of the stock actually provided two separate opportunties for swing trades. First, the initial run out of the gate that took it from 1.12-1.42 (+27%) and a subsequent dip-and-rip pattern from .855 back to 1.12 later on in the day (+31%).

With volatility sufficient to provide over 50% in cumulative gains on the day, and the fact that it maintained support above our designated level, we’ll keep CBIO on our radar for the time being.


Eli Lilly and Co. LLY

On strong 2017 guidance released this week, LLY beat Wall Street’s forecast outlook estimates for the first time in 3 years. As a result, the stock started to climb, and has begun to fill a large gap on the chart to the upside.

What we want to do here is highlight both a short term and extended term options trading idea to correspond with the present situation. For swing trades this week, we’ll look at the LLY Weekly $72 and $72.50 Calls, and to take advantage of the possibility of an extended uptrend, the LLY 01/20 $75 Calls.


Extended Watchlist:
LSCG, TRUU, ERFB, TTCM, AIRW, NDEV, AXPW

Blue Horseshoe Stocks: IDXG, MJPI & More

Interpace Diagnostics Group, Inc. IDXG

We had a few solid performers from yesterday morning’s report, but IDXG was definitely the cream of the crop. We saw a huge initial surge out of the gate followed by a steady ramp-up for the remainder of the session.

From a low of .3619, IDXG traded as high as 1.20, which represents an intraday run of 232% and it occurred on more than eighteen times the 30-day average volume. Not only that, but it managed to close above the dollar mark at 1.01. With price action and momentum like that combined with the fact that we’re seeing another gap-up here in the premarket, we’ll defintiely be on the lookout for further activity today, possibly in the form of a dip-and-rip scenario.

The big move was largely catalyzed by the release of a PR alluding to the fact that Aetna has agreed to cover Interpace’s ThyraMir™ test for all of its 46 million members. (>>View Full PR)


MJP International Ltd. MJPI

MJPI extended its gains yesterday and secured its status as a multi-day runner. We tagged this stock on Wednesday at a low of .85 and witnessed a decent run to 1.18 (+39%). Yesterday we recapped its performance, including the very bullish close and high volume,  and mentioned that a continued run could be in the cards.

We turrned out to be spot on in our assessment, and MJPI persisted in its uptrend, trading up from a morning low of 1.20 and reaching a new high of 1.63. That worked out to an intraday push of 36%, and extended our two-day gains on this play to a highly-respectable 92%


Options Recap

Twitter, Inc. TWTR - After furnishing us with double-bag gains yesterday, our target contracts that we initially put forth last Thursday, the TWTR 01/20 $19 and $20 Calls, recorded some modest intraday gains and added to our cumulative totals.

01/20 $19 Calls – Range: 1.33-1.70 – Max Gain: 28%
01/20 $20 Calls – Range: .94-1.22 – Max Gain: 30%

There is a gap on the TWTR chart that runs from roughly $21-24, and with a 01/20 expiration, we’ll continue to track these options, and if it appears the gap will begin to fill, roll up our strike prices accordingly.
______

Fresh Idea:

Wynn Resorts Ltd. WYNN – We’re looking for a possible recovery play for WYNN in the wake of a damning China UnionPay policy change that implements further restriction of the maximum daily allotment for ATM withdrawals in Macau. With 60% of WYNN’s revenue coming from Macau, the stock got hammered during yesterday’s session.

It appears as if some measure of a recovery will take effect this morning, with the stock gapping up in the premarket, so we’re going to be monitoring the WYNN Weekly $96-98.50 Calls for potential quick-strike trades.


Extended Watchlist:
IMUN, PIOI, LEXG, AXPW, ACNV, MSTX

Blue Horseshoe Stocks: This Week’s Big Runners

Marijuana Company of America, Inc. MCOA

As a part of our general focus on marijuana related stocks, we’ve been hot on the trail of MCOA, first bringing it into the mix early last month (at a low of .0094) and keeping it the conversation all through this week as its gains have gone exponential.

Leading into yesterday’s report, we had already witnessed a move of more than 500% and the stock followed that up with yet another stellar performance on the day. It traded up a solid 70% from a low of .072 to a new high of .1225.

That means that a stock we signaled for observation one month ago tomorrow, went from subpenny and smashed through the dime barrier, which definitely isn’t something you see every day! Neither is a twelve-bagger of any kind, yet the overall run we’ve seen from MCOA in four weeks now amounts to 1203%


Cannabics, Inc. CNBX

CNBX is of course another pot play that we jumped on early last month when we began heavily urging our readers to take heed of the second Green Rush that we’re currently experiencing, and we’ve stuck with it consistently. Subsequent to our report on October 5th we saw it trading for as little as .06, and the epic run it has mounted since then has taken it past the elusive dollar barrier!

Yesterday it posted another nice intraday move going from .75 to 1.12 (+52%) and measuring from that six-cent low, it equates to a remarkable overall run of 1766%


Medical Marijuana, Inc. MJNA

At this point there are so many huge performers in the cannabis space that it’s beginning to become difficult to keep up with all the winners, but we need to take a minute to update our readers on MJNA, which is a play we’ve followed for years.

Like many other pot stocks, it has enjoyed a huge rush of upward movement in recent weeks. We tagged it in our report on September 23rd, saw a low of .04, and yesterday, in a session with absolutely enormous dollar volume, it hit .23. A hefty 475% move has been the result, and as we keep saying, with elections coming in just a few days and medical and recreational marijuana on several ballots, all of these cannabis stocks could still stand to make big swings to the upside.



Galenfeha, Inc. GLFH

Speaking of multi-day runners, starting on Monday morning, we’ve been steadily tracking GLFH through what has been a series of solid daily increases that have amounted to a fairly impressive 3-day run.

As we’ve stated previously, GLFH is a low-volume, low-float play that doesn’t need a whole lot in the way of buying pressure to effect appreciable upward momentum, and we’ve certainly seen that dynamic exemplified.

Yesterday, the stock traded in a range from a low of .0429 on up to a new high of .057, for a daily advance of 33% and a total increase of 119% over our observed low from Monday (.026). In the event of a dip, we’d ideally like to see it maintain support at the 200DMA of .0498. Failing that, we’ll remain interested as long as it doesn’t fall below our witnessed low.


Extended Watchlist:
AXPW, CHK, SGBY, BIOD, NVCR(Bottom-bouncer)

Blue Horseshoe Stocks: Options Recaps & More

Options Roundup

We had put a couple of options ideas in place as we closed out the trading week on Friday, and found success across the board.

Amazon.com, Inc. AMZN – It took the better part of the entire morning on Friday for things to heat up for our AMZN puts, but once they did, it sent our highlighted options contracts on one heck of a ride. Those were the AMZN Weekly $780-772.50 Puts and they allowed for profits both approaching and exceeding ten-bagger territory!

Between roughly noon and 3PM, we saw an significant move to the downside which facilitated the following enormous gains:

$780 Puts – Range: .46-4.80 – Max Gain: 943%
$777.50 Puts – Range: .28-3.32 – Max Gain: 1085%
$775 Puts – Range: .14-1.80 – Max Gain: 1185%
$772.50 Calls – Range: .08-1.03 – Max Gain: 1187%

_____

Royal Caribbean Cruises, Ltd RCL – The contracts we chose for the RCL chain were the RCL 11/18 $67.50-72.50 Calls. These are extended term contracts with plenty of time left until expiration, which explains why the premiums were so high, and the moves were of a lesser magnitude than AMZN. Still, for a first day, we did see some notable gain opportunities, including a double-bagger:

$67.50 Calls – Range: 5.30-7.80 – Max Gain: 47%
$70 Calls – Range: 3.30-5.80 – Max Gain: 76%
$72.50 Calls – Range: 1.70-3.85 – Max Gain: 126%


Axion Power International, Inc. AXPW

We want to circle back to this old familiar play, which up until the past couple of weeks, had been on a continuous downslide for quite some time. Due to a number of factors, we’ll be interested in tracking the stock’s progress off of its recently registered annual lows.

On Friday, the stock made a nice move and temporarily cracked the 50DMA at .0131, which will be the key area of resistance of which we’ll be watching for a sustained break. As you can see on the chart below, the stock recently woke up off of being heavily oversold for an extended period, and we’re going to want to track every step of its recovery.


Extended Watchlist:
AKAO, MMEG, USRM, ZRZH, MGON, GLFH